Zobrazeno 1 - 4
of 4
pro vyhledávání: ''
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Breast cancer (BC) is one of the most common malignant tumor, the incidence of which has increased worldwide in recent years. Ginsenosides are the main active components of Panax ginseng C. A. Mey., in vitro and in vivo studies have confirmed that gi
Externí odkaz:
https://doaj.org/article/591e1ffe439c4b5bb1b56736cb4f8c7e
Autor:
Umar Mehraj, Nissar Ahmad Wani, Abid Hamid, Mustfa Alkhanani, Abdullah Almilaibary, Manzoor Ahmad Mir
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Although advances in diagnostics and therapeutics have prolonged the survival of triple-negative breast cancer (TNBC) patients, metastasis, therapeutic resistance, and lack of targeted therapies remain the foremost hurdle in the effective management
Externí odkaz:
https://doaj.org/article/e25dcab2afa949f89ef3b4c3de36057d
Autor:
Nannan Wang, Yan Yang, Dongdong Jin, Zhenan Zhang, Ke Shen, Jing Yang, Huanhuan Chen, Xinyue Zhao, Li Yang, Huaiwu Lu
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Breast cancer and gynecological tumors seriously endanger women’s physical and mental health, fertility, and quality of life. Due to standardized surgical treatment, chemotherapy, and radiotherapy, the prognosis and overall survival of cancer patie
Externí odkaz:
https://doaj.org/article/6ff33ea9e7884f80ad5ebd6830245c48
Autor:
Xu-Jing Li, Wen-Tong Li, Zi-Hao-Ran Li, Li-Ping Zhang, Cheng-Cheng Gai, Wei-Fen Zhang, De-Jun Ding
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Combination therapy which enhances efficacy and reduces toxicity, has been increasingly applied as a promising strategy for cancer therapy. Here, a reactive oxygen species (ROS) that enhanced combination chemotherapy nanodevices was fabricated based
Externí odkaz:
https://doaj.org/article/e647151eb62241c08d80625dbd609fe2